Manufacturers Life Insurance Company, The Pds Biotechnology Corp Call Options Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.16MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$6.98 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$769,4070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$691,8510.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$406,3760.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $45M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...